基于灌注的侧支循环指标预测急性缺血性卒中患者梗死增长:一项多中心对比分析
这项回顾性多中心研究纳入116例前循环大血管闭塞且成功再灌注的急性缺血性卒中患者,比较HIR、rCBV指数和PCI对梗死显著增长(最终梗死体积较基线缺血核心增加≥10 mL)的预测能力。58例(50%)出现梗死增长;PCI和rCBV指数判定的不良侧支与梗死增长显著相关(P<.01),HIR则不相关(P=.83);多因素分析中基线NIHSS评分、rCBV指数和PCI为独立预测因子。
要点
- rCBV指数和PCI判定的不良侧支与梗死增长显著相关(P<.01),HIR不相关(P=.83)。
- 梗死显著增长定义为最终梗死体积较基线缺血核心体积增加≥10 mL。
- 多因素分析中基线NIHSS评分、rCBV指数和PCI为梗死增长的独立预测因子。
核心结论
- 整合CBV的灌注侧支指标(rCBV指数和PCI)在预测急性缺血性卒中患者显著梗死增长方面优于基于延迟的HIR,可能在治疗决策、患者转运决策和预后判断中发挥重要作用。
研究设计与样本
- 回顾性多中心研究,纳入116例前循环大血管闭塞患者,均具备治疗前灌注(CT或MR)、成功再灌注(modified TICI ≥ 2b)及治疗后24–48小时内随访MRI;HIR和rCBV指数用RAPID软件(Version 5.0.4)计算,PCI用Olea软件(SP.23)计算。
诊断标准与关键数值
- HIR定义为Tmax >10秒体积除以Tmax >6秒体积;rCBV指数定义为Tmax >6秒体积内rCBV均值;PCI定义为delay2–6秒体积乘以其对应平均rCBV;主要结局为梗死显著增长,即最终梗死体积较基线缺血核心体积≥10 mL。
临床应用与阅片要点
- 作者认为整合CBV的灌注侧支指标(rCBV指数和PCI)在预测显著梗死增长方面优于基于延迟的HIR,可能用于治疗决策、患者转运决策和预后判断。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: In patients with acute ischemic stroke (AIS), robust collaterals are associated with lower rates of infarct growth. Perfusion-based collateral matrices, including hypoperfusion intensity ratio (HIR), relative CBV (rCBV) index, and perfusion collateral index (PCI), have been used successfully to assess collaterals in patients with AIS. We aimed to assess and compare the diagnostic ability of these perfusion-based collateral indices in the prediction of infarct growth in patients with AIS after successful reperfusion.
MATERIALS AND METHODS: In this retrospective multicenter study, patients with anterior circulation large vessel occlusion were included if they had pretreatment perfusion (CT or MR), successful reperfusion (modified TICI ≥ 2b), and follow-up MRI within 24-48 hours from the date of treatment. The primary outcome assessed was substantial infarct growth, which was defined as a final infarct volume of ≥10 mL compared with the baseline ischemic core volume. Perfusion-based collateral indices including HIR (volume of time-to-maximum [Tmax] >10 seconds/volume of Tmax >6 seconds) and rCBV index (mean of rCBV values within the volume of Tmax > 6 seconds) were calculated using RAPID software (Version 5.0.4), and PCI (volume of delay2-6 seconds multiplied by its corresponding mean rCBV) was calculated using Olea software (SP.23). The association between perfusion-based collateral indices, along with demographic and clinical variables for determination of infarct growth, was tested using appropriate univariate analysis. Multivariable logistic regression using a stepwise backward selection approach was performed to identify independent predictors of infarct growth.
RESULTS: Among 116 included patients, 58 (50%) had infarct growth ≥10 mL. Infarct growth volume (median, interquartile range) was: 11, 2.6-34.7 mL. Poor collaterals determined by PCI and rCBV index was significantly (P < .01) associated with infarct growth, whereas HIR was not (P = .83). Following multivariate logistic regression, 3 variables remained as independent predictors of infarct growth: baseline National Institutes of Health Stroke Scale (OR = 1.10; 95% CI: 1.02-1.15; P = .005); rCBV index (OR = 0.005; 95% CI: 0.00-0.14; P = .002); and PCI (OR = 0.99; 95% CI: 0.98-0.99; P = .01).
CONCLUSIONS: Perfusion-based collateral indices that integrate CBV (rCBV index and PCI) outperformed delay-based HIR in the prediction of substantial infarct growth in patients with AIS, and may play an important role in treatment decision-making, patient transfer decisions, and prognostication.
引用
- McArthur M, Asghariahmadabad M, Thomas M, et al. Perfusion-Based Collaterals in Prediction of Infarct Growth in Patients with Acute Ischemic Stroke: A Multicenter Comparative Analysis. AJNR Am J Neuroradiol. 2026. PMID: 41813071. doi:10.3174/ajnr.A9288
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。